LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Clark, P.; Walker, I.D.; Govan, L.; Wu, O.; Greer, I.A. (2008)
Publisher: Blackwell
Languages: English
Types: Article
Subjects: RC, RG
Factor V Leiden (FVL) and ABO(H) blood groups are the common influences on haemostasis and retrospective studies have linked FVL with pregnancy complications. However, only one sizeable prospective examination has taken place. As a result, neither the impact of FVL in unselected subjects, any interaction with ABO(H) in pregnancy, nor the utility of screening for FVL is defined. A prospective study of 4250 unselected pregnancies was carried out. A venous thromboembolism (VTE) rate of 1·23/1000 was observed, but no significant association between FVL and pre-eclampsia, intra-uterine growth restriction or pregnancy loss was seen. No influence of FVL and/or ABO(H) on ante-natal bleeding or intra-partum or postpartum haemorrhage was observed. However, FVL was associated with birth-weights >90th centile [odds ratio (OR) 1·81; 95% confidence interval (CI95) 1·04–3·31] and neonatal death (OR 14·79; CI95 2·71–80·74). No association with ABO(H) alone, or any interaction between ABO(H) and FVL was observed. We neither confirmed the protective effect of FVL on pregnancy-related blood loss reported in previous smaller studies, nor did we find the increased risk of some vascular complications reported in retrospective studies.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • Bos, M.H.A., Meijerman, D.W.E., Van Der Zwaan, C. & Mertens, K. (2005) Does activated protein C-resistant factor V contribute to thrombin generation in hemophilic plasma? Journal of Thrombosis and Haemostasis, 3, 522-530.
    • Carstairs, V. (1995) Deprivation indices: their interpretation and use in relation to health. Journal of Epidemiology and Community Health, 49, S3-S8.
    • Cashner, K., Christopher, C. & Dysert, G. (1987) Spontaneous fetal loss after demonstration of a live fetus in the frist trimester. Obstetrics and Gynecology, 70, 827-830.
    • Castoldi, E., Govers-Riemslag, J.W.P., Pinotti, M., Bindini, D., Tans, G., Berrettini, M., Mazzucconi, M.G., Bernardi, F. & Rosing, J. (2003) Coinheritance of factor V (FV) Leiden enhances thrombin formation and is associated with a mild bleeding phenotype in patients homozygous for the FVII 9726+5G>A (FVII Lazio) mutation. Blood, 102, 4014-4020.
    • Catalano, P. & Ehrenberg, H. (2006) The short- and long-term implications of maternal obseity on the mother and her offspring. An International Journal of Obstetrics and Gynaecology, 113, 1126-1133.
    • Clark, P., Sattar, N., Walker, I. & Greer, I. (2001) The Glasgow outcome, APCR and lipid (GOAL) pregnancy study: significance of pregnancy associated activated protein C resistance. Thrombosis and Haemostasis, 85, 30-35.
    • Clark, P., Meiklejohn, D., O'Sullivan, A., Vickers, M. & Greaves, M. (2005) The relationship of ABO, Lewis and secretor blood groups with cerebral ischaemia of arterial origin. Journal of Thrombosis and Haemostasis, 3, 2105-2108.
    • Corral, J., Iniesta, J.A., Gonzalez-Conejero, R., Villalon, M. & Vicente, V. (2001) Polymorphisms of clotting factors modify the risk for primary intracranial hemorrhage. Blood, 97, 2979-2982.
    • Donahue, B.S., Gailani, D., Higgins, M.S., Drinkwater, D.C. & George, A.L. (2003) Factor V Leiden protects against blood loss and transfusion after cardiac surgery. Circulation, 107, 1003-1008.
    • Duthie, S., Ven, D., Yung, G., Chan, S. & Ma, H. (1991) Discrepancy between laboratory determination and visual inspection of blood loss during normal delivery. European Journal of Obstetrics Gynecology and Reproductive Biology, 38, 119-124.
    • Escuriola Ettingshausen, C., Halimeh, S., Kurnik, K., Schobess, R., Wermes, C., Junker, R., Kreuz, W., Pollmann, H. & Nowak-Gottl, U. (2001) Symptomatic onset of severe hemophilia A in childhood is dependent on the presence of prothrombotic risk factors. Thrombosis and Haemostasis, 85, 218-220.
    • Gill, A., Endres-Brooks, J., Bauer, P., Marks, W. & Montgomery, R. (1987) The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood, 69, 1691-1695.
    • Gonzalez Ordonez, A.J., Medina Rodriguez, J.M., Martin, L., Alvarez, V. & Coto, E. (1999) The O blood group protects against venous thromboembolism in individuals with the factor V Leiden but not the prothrombin (factor II G20210A) mutation. Blood Coagulation and Fibrinolysis, 10, 303-307.
    • Greer, I. & Thomson, A. (2001) Management of venous thromboembolism in pregnancy. Best Practice and Research in Clinical Obstetrics and Gynaecology, 15, 583-603.
    • Harlap, S. & Davies, A.M. (1974) Maternal blood group A and pre-eclampsia. British Medical Journal, 3, 171-172.
    • Jick, H., Slone, D., Westerholm, B., Inman, W.H., Vessey, M.P., Shapiro, S., Lewis, G.P. & Worcester, J. (1969) Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet, 1, 539-542.
    • Klerk, M., Verhoef, P., Clarke, R., Blom, H., Kok, F. & Schouten, E. (2002) MTHFR 677C fi T polymorphism and risk of coronary artery disease: a meta-analysis. The Journal of American Medical Association, 288, 2023-2031.
    • Koster, T., Blann, A.D., Briet, E., Vandenbroucke, J.P. & Rosendaal, F.R. (1995) Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet, 345, 152-155.
    • Larsen, T.B., Johnsen, S.P., Gislum, M., Moller, C.A., Larsen, H. & Sorensen, H.T. (2005) ABO blood groups and risk of venous thromboembolism during pregnancy and the puerperium. A population-based, nested case-control study. Journal of Thrombosis and Haemostasis, 3, 300-304.
    • Lindqvist, P.G., Svensson, P.J., Dahlback, B. & Marsal, K. (1998) Factor V Q506 mutation (activated protein C resistance) associated with reduced intrapartum blood loss - a possible evolutionary selection mechanism. Thrombosis and Haemostasis, 79, 69-73.
    • Lindqvist, P., Svensson, P., Marsal, K., Grennert, L., Lutekort, M. & Dahlback, B. (1999) Activated protein C resistance (FV:Q506) and pregnancy. Thrombosis and Haemostasis, 81, 532-537.
    • May, D. (1973) Maternal blood group A and pre-eclampsia. British Medical Journal, 4, 22.
    • Morelli, V., De Visser, M., Vos, H., Bertina, R. & Rosendaal, F. (2005) ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden. Journal of Thrombosis and Haemostasis, 3, 183-185.
    • Morris, R. & Carstairs, V. (1991) Which deprivation? A comparison of selected deprivation indexes. Journal of Public Health Medicine, 13, 318-326.
    • Neerhof, M. (1995) Causes of intrauterine growth restriction. Clinical Perinatology, 22, 375-385.
    • Preston, A. & Barr, A. (1964) The plasma concentration of factor VIII in the population. British Journal of Haematology, 10, 238-245.
    • Pritchard, J. (1965) Changes in blood volume during pregnancy and delivery. Anesthesiology, 26, 393-399.
    • Robert, A., Aillaud, M.f., Eschwege, V., Randrianjohany, A., Scarabin, Y. & Juhan-Vague, I. (2000) ABO blood group and risk of venous thrombosis in heterozygous carriers of factor V Leiden. Thrombosis and Haemostasis, 83, 630-631.
    • Robertson, L., Wu, O., Langhorne, P., Twaddle, S., Clark, P., Lowe, G., Walker, I., Greaves, M., Brenkel, I., Regan, L. & Greer, I. (2006) Thrombophilia in pregnancy: a systematic review. British Journal of Haematology, 132, 171-196.
    • Samueloff, A., Xenakis, E., Berkus, M., Huff, R. & Langer, O. (1993) Recurrent stillbirth: significance and characteristics. Journal of Reproductive Medicine, 38, 883-886.
    • Sezik, M., Toyran, H. & Yapar, E.G. (2002) Distribution of ABO and Rh blood groups in patients with HELLP syndrome. Archives of Gynecology & Obstetrics, 267, 33-36.
    • South, J. & Naldrett, J. (1974) Maternal blood group A and pre-eclampsia. British Medical Journal, 1, 30.
    • van 't Veer, C., Golden, N.J., Kalafatis, M., Simioni, P., Bertina, R.M. & Mann, K.G. (1997) An in vitro analysis of the combination of hemophilia A and factor V(LEIDEN). Blood, 90, 3067-3072.
    • Walker, I. (2000) Thrombophilia in pregnancy. Journal of Clinical Pathology, 53, 573-580.
  • No related research data.
  • No similar publications.

Share - Bookmark

Download from

Cite this article